Literature DB >> 11527630

The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: a population-based study of four decades.

K Matsuo1, M Akahoshi, E Nakashima, A Suyama, S Seto, M Hayano, K Yano.   

Abstract

OBJECTIVES: We sought to demonstrate the prevalence, incidence and prognostic value of the Brugada-type electrocardiogram (ECG) in a general population.
BACKGROUND: The Brugada syndrome is characterized by evidence of right bundle branch block and ST segment elevation in the right precordial leads, as well as sudden death caused by ventricular fibrillation. However, the natural history of the Brugada-type ECG remains unclear.
METHODS: We investigated 4,788 subjects (1,956 men and 2,832 women) who were <50 years old in 1958 and had undergone biennial health examinations, including electrocardiography, through 1999. The Brugada-type ECG was defined as a terminal r' wave in lead V(1) and ST segment elevation > or =0.1 mV in leads V(1) and V(2). Unexpected death was defined as sudden death or unexplained accidental death.
RESULTS: There were a total of 32 Brugada-type ECG cases; the prevalence and incidence were 146.2 in 100,000 persons and 14.2 persons per 100,000 person-years, respectively. The incidence was nine times higher among men than women, and the average age at presentation was 45 +/- 10.5 years. The Brugada-type ECG appeared intermittently in most cases and was found in 26% of subjects who died unexpectedly. Cox survival analysis revealed that mortality from unexpected death was significantly higher in subjects with a Brugada-type ECG than in control subjects (p < 0.01). Unexpected deaths were more frequent among subjects with the Brugada-type ECG who had a history of syncope (p < 0.05).
CONCLUSIONS: The Brugada-type ECG is not a very rare condition in the adult Japanese population. Subjects with a Brugada-type ECG have an increased risk of unexpected death.

Entities:  

Mesh:

Year:  2001        PMID: 11527630     DOI: 10.1016/s0735-1097(01)01421-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  30 in total

1.  [Brugada syndrome].

Authors:  Christian Wolpert; Claudia Herrera-Siklody; Ulli Parade; Christian Strotmann; Norman Rüb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-12

2.  Brugada Pattern in Diabetic Ketoacidosis: A Case Report and Scoping Study.

Authors:  Syed Haseeb; Pramod Theetha Kariyanna; Apoorva Jayarangaiah; Ganesh Thirunavukkarasu; Sudhanva Hegde; Jonathan D Marmur; Sneha Neurgaonkar; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018-10-07

3.  Extracorporeal Life Support as a Rescue Measure for Managing Life-Threatening Arrythmia and Brugada Syndrome.

Authors:  Asaad G Beshish; Allison Weinberg; Waseem Ostwani; Gabe E Owens
Journal:  J Extra Corpor Technol       Date:  2017-12

4.  Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest.

Authors:  Takanori Ikeda; Mitsuaki Takami; Kaoru Sugi; Yuka Mizusawa; Harumizu Sakurada; Hideaki Yoshino
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

Review 5.  Brugada Syndrome:Risk Stratification And Management.

Authors:  Yoshifusa Aizawa
Journal:  J Atr Fibrillation       Date:  2016-10-31

Review 6.  Impact of sex and ethnicity on arrhythmic risk.

Authors:  Santosh Rane; Kristen K Patton
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

Review 7.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

Review 8.  Brugada and long QT-3 syndromes: two phenotypes of the sodium channel disease.

Authors:  Ijaz A Khan; Chandra K Nair
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

9.  Brugada syndrome with elevated cardiac biomarkers.

Authors:  Fatima AlKendi; Mujgan Jamil; Anwer Qureshi; Gohar Jamil
Journal:  BMJ Case Rep       Date:  2013-06-27

Review 10.  Risk stratification and treatment of brugada syndrome.

Authors:  Elena Arbelo; Josep Brugada
Journal:  Curr Cardiol Rep       Date:  2014-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.